Abstract
The p53 family consists of three transcription factors, p53, p63 and p73 that share domain architecture and sequence identity. The mTOR (mammalian target of rapamycin) kinase responds to growth factors and nutrient levels to regulate cellular growth and autophagy. Whereas p53 acts both upstream and downstream of mTOR, gene signature-based analyses have revealed that p73 is inhibited by mTOR activity. p53 can both activate and repress autophagy levels depending on cellular context. While less is known about p73, recent studies have shown that it induces cellular autophagy and multiple autophagy-associated genes downstream of mTOR. Chromatin immunoprecipitation analyses demonstrate that endogenous p73 binds the regulatory regions of genes such as ATG5, ATG7 and UVRAG. How p73 regulates the expression levels of these genes in response to different cellular stresses remains unknown. Because p53 family members play key roles in tumor suppression, development, aging and neurodegeneration, the context and manner by which these transcription factors regulate autophagy may have implications for a wide range of human diseases.
MeSH Terms
Animals
Autophagy/genetics
Base Sequence
Gene Expression Regulation
Humans
Mice
Molecular Sequence Data
Protein Kinases/metabolism
TOR Serine-Threonine Kinases
Tumor Suppressor Proteins/metabolism
Chemicals
Tumor Suppressor Proteins
Protein Kinases
MTOR protein, human
mTOR protein, mouse
TOR Serine-Threonine Kinases
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Rosenbluth Jennifer M
Department of Biochemistry, Center in Molecular Toxicology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Pietenpol Jennifer A
References (25)
25 references, click to expand
-
p63 and p73 in human cancer: defining the network.
Oncogene. 2007 Aug 9;26(36):5169-83
PMID: 17334395
-
Therapeutic prospects for p73 and p63: rising from the shadow of p53.
Drug Resist Updat. 2008 Aug-Oct;11(4-5):152-63
PMID: 18801697
-
p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours.
Nature. 2000 Mar 2;404(6773):99-103
PMID: 10716451
-
The jury is in: p73 is a tumor suppressor after all.
Genes Dev. 2008 Oct 1;22(19):2591-5
PMID: 18832062
-
The Arf/p53 pathway in cancer and aging.
Cancer Res. 2008 Aug 1;68(15):6031-4
PMID: 18676821
-
Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53.
EMBO J. 2007 Nov 28;26(23):4812-23
PMID: 17962806
-
p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling.
Cell. 2008 Aug 8;134(3):451-60
PMID: 18692468
-
Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG.
Nat Cell Biol. 2006 Jul;8(7):688-99
PMID: 16799551
-
p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death.
Cell Death Differ. 2007 Jun;14(6):1071-9
PMID: 17304243
-
TAp73 knockout shows genomic instability with infertility and tumor suppressor functions.
Genes Dev. 2008 Oct 1;22(19):2677-91
PMID: 18805989
-
DRAM, a p53-induced modulator of autophagy, is critical for apoptosis.
Cell. 2006 Jul 14;126(1):121-34
PMID: 16839881
-
Targeting the p53 family for cancer therapy: 'big brother' joins the fight.
Cell Cycle. 2007 Aug 15;6(16):1995-2000
PMID: 17721076
-
Characterization of genome-wide p53-binding sites upon stress response.
Nucleic Acids Res. 2008 Jun;36(11):3639-54
PMID: 18474530
-
Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells.
Mol Cell. 2006 Nov 17;24(4):593-602
PMID: 17188034
-
The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.
Cancer Res. 2007 Apr 1;67(7):3043-53
PMID: 17409411
-
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.
Nature. 1999 Apr 22;398(6729):714-8
PMID: 10227294
-
The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers.
J Clin Invest. 2007 May;117(5):1370-80
PMID: 17446929
-
p73 regulates neurodegeneration and phospho-tau accumulation during aging and Alzheimer's disease.
Neuron. 2008 Sep 11;59(5):708-21
PMID: 18786355
-
Regulation of autophagy by cytoplasmic p53.
Nat Cell Biol. 2008 Jun;10(6):676-87
PMID: 18454141
-
A gene signature-based approach identifies mTOR as a regulator of p73.
Mol Cell Biol. 2008 Oct;28(19):5951-64
PMID: 18678646
-
A global map of p53 transcription-factor binding sites in the human genome.
Cell. 2006 Jan 13;124(1):207-19
PMID: 16413492
-
Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking.
Nat Cell Biol. 2008 Jul;10(7):776-87
PMID: 18552835
-
p63 deficiency activates a program of cellular senescence and leads to accelerated aging.
Genes Dev. 2005 Sep 1;19(17):1986-99
PMID: 16107615
-
The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease.
Science. 2006 Sep 29;313(5795):1929-35
PMID: 17008526
-
The effects of p53 on whole organism longevity are mediated by autophagy.
Autophagy. 2008 Oct;4(7):870-3
PMID: 18728385